Novo Owner to Build $62 Million Quantum Chip Plant in Denmark
AI Summary
Novo Nordisk's parent entity is backing a $62 million quantum chip manufacturing facility in Denmark targeting life sciences.
Novo Holdings, the controlling owner of healthcare giant Novo Nordisk, is committing $62 million to build a dedicated quantum chip production plant in Denmark.
The investment aims to accelerate quantum hardware research and manufacturing within the Nordic region, specifically targeting life sciences and biotechnology applications such as molecular simulation and drug discovery.
The development marks an increasing trend of healthcare-focused sovereign and institutional investors funding quantum infrastructure to bolster foundational pharmaceutical research capabilities.
Related News
EPB Launches Commercial Quantum Utility in Chattanooga
EPB has switched on an IonQ Forte Enterprise quantum computer, marking the first time a U.S. utility site has integrated commercial quantum computing and networking.
New benchmark, QuSquare, tests near-term quantum devices
A new benchmarking tool called QuSquare has been introduced to evaluate the performance of near-term quantum devices.
Users Emerge for Albuquerque, N.M., Quantum Network
A new quantum network in Albuquerque is seeing its first wave of users, marking a transition toward regional quantum communication infrastructure.